Correlation Between Citius Oncology, and Amphastar

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Citius Oncology, and Amphastar at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citius Oncology, and Amphastar into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citius Oncology, and Amphastar P, you can compare the effects of market volatilities on Citius Oncology, and Amphastar and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citius Oncology, with a short position of Amphastar. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citius Oncology, and Amphastar.

Diversification Opportunities for Citius Oncology, and Amphastar

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Citius and Amphastar is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Citius Oncology, and Amphastar P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amphastar P and Citius Oncology, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citius Oncology, are associated (or correlated) with Amphastar. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amphastar P has no effect on the direction of Citius Oncology, i.e., Citius Oncology, and Amphastar go up and down completely randomly.

Pair Corralation between Citius Oncology, and Amphastar

Given the investment horizon of 90 days Citius Oncology, is expected to generate 3.91 times more return on investment than Amphastar. However, Citius Oncology, is 3.91 times more volatile than Amphastar P. It trades about 0.1 of its potential returns per unit of risk. Amphastar P is currently generating about -0.2 per unit of risk. If you would invest  59.00  in Citius Oncology, on January 14, 2025 and sell it today you would earn a total of  8.10  from holding Citius Oncology, or generate 13.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Citius Oncology,  vs.  Amphastar P

 Performance 
       Timeline  
Citius Oncology, 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Citius Oncology, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in May 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Amphastar P 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Amphastar P has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in May 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Citius Oncology, and Amphastar Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Citius Oncology, and Amphastar

The main advantage of trading using opposite Citius Oncology, and Amphastar positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citius Oncology, position performs unexpectedly, Amphastar can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amphastar will offset losses from the drop in Amphastar's long position.
The idea behind Citius Oncology, and Amphastar P pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Transaction History
View history of all your transactions and understand their impact on performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges